Larvol Delta - Acumen-Pharmaceuticals-to-Hold-Conference-Call-to-Discuss-Positive-Topline-Results-from-FirstinHuman-Phase-1-Study-of-ACU193-for-Early-Alzheimers-Disease

ACU193 - Acumen Pharma

https://www.globenewswire.com/news-release/2023/07/17/2705483/0/en/Acumen-Pharmaceuticals-to-Hold-Conference-Call-to-Discuss-Positive-Topline-Results-from-First-in-Human-Phase-1-Study-of-ACU193-for-Early-Alzheimer-s-Disease.html

Jul 17, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next